Antibodies News and Research

RSS

Study reveals impact of hybrid immunity and booster vaccination on antibody waning

The decline in neutralizing antibody (nAb) titers following COVID-19 vaccination.

24 Oct 2023

Utilizing Biomarkers in Cancer Prevention, Diagnosis, and Treatment

In this interview, Grace Liu from Sino Biological discusses the crucial role of biomarkers in cancer prevention and diagnosis and how they can help guide treatment decisions.

From Sino Biological Inc. 24 Oct 2023

Intranasal vaccination: A potent one-time solution for comprehensive COVID-19 immunity

A single-dose intranasal vaccine effectively induces robust immune responses.

24 Oct 2023

Canine transmission models provide insights into the neurological impacts of COVID-19 on human brains

The histopathologic alteration caused by SARS‑CoV‑2 on mammalian neurological systems.

20 Oct 2023

Low serotonin levels observed in long COVID and other viral infections

Researchers identify a pathophysiological mechanism linking serotonin reduction to the multifaceted etiology of post-acute sequelae of COVID-19.

20 Oct 2023

Biden pick to lead NIH finally has her day, but still gets caught up in drug price debate

A Senate committee finally held a hearing Wednesday on President Joe Biden's pick to lead the National Institutes of Health. But the panel's chair, Sen. Bernie Sanders (I-Vt.), was focused on drug prices — an issue over which the NIH has very little control.

19 Oct 2023

New method uses extracellular vesicles to enhance immunotherapy responses in glioblastoma

A team of researchers at The University of Texas MD Anderson Cancer Center has developed a new method for using extracellular vesicles to enhance responses to immunotherapy in glioblastoma, potentially opening the door for wider use of engineered messenger RNA (mRNA) for cancer therapy.

19 Oct 2023

Pan-coronavirus vaccine shows success in mouse studies

A vaccine designed to protect against three different deadly coronaviruses shows success in mouse studies, demonstrating the viability of a pan-coronavirus vaccine developed by researchers at the Duke Human Vaccine Institute.

18 Oct 2023

Study sheds light on how NAD+ levels decline with age in the ovaries, affecting fertility

A woman's fertility normally decreases by her late 30s with reproductive function eventually ceasing at menopause.

18 Oct 2023

Precision oncology therapies account for nearly half of new cancer drug approvals since 1998

Of the 198 new oncology drugs approved by the U.S. Food and Drug Administration (FDA) between 1998 and 2022, approximately 43% were precision oncology therapies, the use of which is guided by biomarker testing.

18 Oct 2023

Researchers develop experimental vaccine to prevent spread of metastatic cancers to the lungs

Engineers at the University of California San Diego have developed an experimental vaccine that could prevent the spread of metastatic cancers to the lungs.

18 Oct 2023

New treatment options offer hope for patients with non-small cell lung cancer

More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumour cells, with less need for chemotherapy, following results of multiple landmark clinical trials reported for the first time in late-breaking presentations at the ESMO Congress 2023 (1-7).

17 Oct 2023

Shaping the Future of Therapeutics with 3D Imaging Mass Cytometry

In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Laura Kuett, a Ph.D. student in Systems Biology, about the promise of 3D Imaging Mass Cytometry.

17 Oct 2023

Live vaccinations found to be safe for pediatric organ transplant recipients

Live vaccinations provided to children who previously received liver or kidney transplants were found to be safe and prompted an immune response to guard against several life-threatening conditions, according to a new study published Oct. 12, 2023, in JAMA Network Open.

16 Oct 2023

Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics

Antiverse Ltd (Antiverse) and GlobalBio, Inc. (GlobalBio) today announced they will be extending their collaboration to advance immune checkpoint inhibitors in cancer therapy.

From Antiverse 16 Oct 2023

Is it time to rethink COVID-19 boosters? New study dives into variant-specific vaccines

The study explores the efficacy of variant-adapted COVID-19 booster vaccines, particularly against new strains like Omicron. It raises questions about the need for annual updates and the best technologies for long-term, durable immunity.

15 Oct 2023

Are people with HIV at a higher risk of severe COVID-19 outcomes?

The research review indicates that people with HIV, especially those with low CD4 cell counts, face greater risks of severe COVID-19 outcomes and have suboptimal immune responses to SARS-CoV-2. Antiretroviral therapy aids in clearing infections, and a third vaccine dose reduces the risk of breakthrough infections among this population.

15 Oct 2023

Strong antibody response and nasal cytokines may protect young children from severe COVID-19

New research helps explain why young children have lower rates of severe COVID-19 than adults. A study of infants and young children found those who acquired SARS-CoV-2 had a strong, sustained antibody response to the virus and high levels of inflammatory proteins in the nose but not in the blood.

13 Oct 2023

Nongenetic mechanisms play a role in lung cancer treatment resistance

In a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan Chair in Medical Oncology, a team of researchers from City of Hope, one of the largest cancer research and treatment organizations in the United States, and other institutions found that nongenetic mechanisms are important in lung cancer patients who develop a resistance to one cancer therapy.

13 Oct 2023

BIOHIT HealthCare to host webinar exploring TDM in gastrointestinal medicine

BIOHIT HealthCare is excited to announce its upcoming webinar entitled Proactive vs reactive therapeutic drug monitoring in inflammatory bowel disease (IBD).

From BIOHIT HealthCare Ltd 13 Oct 2023

Antibodies News and Research

Study reveals impact of hybrid immunity and booster vaccination on antibody waning

Utilizing Biomarkers in Cancer Prevention, Diagnosis, and Treatment

Intranasal vaccination: A potent one-time solution for comprehensive COVID-19 immunity

Canine transmission models provide insights into the neurological impacts of COVID-19 on human brains

Low serotonin levels observed in long COVID and other viral infections

Biden pick to lead NIH finally has her day, but still gets caught up in drug price debate

New method uses extracellular vesicles to enhance immunotherapy responses in glioblastoma

Pan-coronavirus vaccine shows success in mouse studies

Study sheds light on how NAD+ levels decline with age in the ovaries, affecting fertility

Precision oncology therapies account for nearly half of new cancer drug approvals since 1998

Researchers develop experimental vaccine to prevent spread of metastatic cancers to the lungs

New treatment options offer hope for patients with non-small cell lung cancer

Shaping the Future of Therapeutics with 3D Imaging Mass Cytometry

Live vaccinations found to be safe for pediatric organ transplant recipients

Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics

Is it time to rethink COVID-19 boosters? New study dives into variant-specific vaccines

Are people with HIV at a higher risk of severe COVID-19 outcomes?

Strong antibody response and nasal cytokines may protect young children from severe COVID-19

Nongenetic mechanisms play a role in lung cancer treatment resistance

BIOHIT HealthCare to host webinar exploring TDM in gastrointestinal medicine

How to make hybridoma-based antibody discovery more efficient eBook

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest Life Science News